Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 349721, 7 pages
http://dx.doi.org/10.1155/2015/349721
Research Article

Hypotensive and Angiotensin-Converting Enzyme Inhibitory Activities of Eisenia fetida Extract in Spontaneously Hypertensive Rats

Department of Pharmacology, Key Laboratory of Applied Pharmacology of Shandong Province, Weifang Medical University, Weifang, Shandong 261053, China

Received 20 October 2015; Accepted 30 November 2015

Academic Editor: Waris Qidwai

Copyright © 2015 Shumei Mao and Chengde Li. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Takenaka, K. Sueyoshi, J. Arai et al., “Calcium channel blockers suppress daily variations of blood pressure in hypertensive patients with end-stage renal diseases,” Clinical and Experimental Hypertension, vol. 36, no. 2, pp. 78–82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Grabska, G. Gromadzka, and A. Członkowska, “Prestroke antihypertensive therapy: effect on the outcome,” Clinical and Experimental Hypertension, vol. 35, no. 2, pp. 141–147, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. N. Fursov, N. P. Potekhin, F. A. Orlov, and E. G. Zakharova, “Evolution of treatment options for hypertension,” Voenno-Meditsinskiĭ Zhurnal, vol. 334, no. 7, pp. 26–31, 2013. View at Google Scholar
  4. M. Briet and E. L. Schiffrin, “Treatment of arterial remodeling in essential hypertension,” Current Hypertension Reports, vol. 15, no. 1, pp. 3–9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. C. van Vark, M. Bertrand, K. M. Akkerhuis et al., “Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients,” European Heart Journal, vol. 33, no. 16, pp. 2088–2097, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama, “The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease,” Pharmacological Reviews, vol. 59, no. 3, pp. 251–287, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Ichihara, H. Kobori, A. Nishiyama, and L. G. Navar, “Renal renin-angiotensin system,” Contributions to Nephrology, vol. 143, pp. 117–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Paul, A. P. Mehr, and R. Kreutz, “Physiology of local renin-angiotensin systems,” Physiological Reviews, vol. 86, no. 3, pp. 747–803, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. W. W. Schulz, H. K. Hagler, L. M. Buja, and E. G. Erdös, “Ultrastructural localization of angiotensin I-converting enzyme (EC 3.4.15.1) and neutral metalloendopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney,” Laboratory Investigation, vol. 59, no. 6, pp. 789–797, 1988. View at Google Scholar · View at Scopus
  10. W. C. De Mello and A. H. J. Danser, “Angiotensin II and the heart: on the intracrine renin-angiotensin system,” Hypertension, vol. 35, no. 6, pp. 1183–1188, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Clarke, M. Flores-Muñoz, C. A. McKinney, G. Milligan, and S. A. Nicklin, “Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system,” Future Cardiology, vol. 9, no. 1, pp. 23–38, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Katragadda and R. R. Arora, “Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects,” American Journal of Therapeutics, vol. 17, no. 1, pp. e11–e23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Mohamad Ansor, N. Abdullah, and N. Aminudin, “Anti-angiotensin converting enzyme (ACE) proteins from mycelia of Ganoderma lucidum (Curtis) P. Karst,” BMC Complementary and Alternative Medicine, vol. 13, article 256, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. D.-Z. Liu, Y.-C. Liang, S.-Y. Lin et al., “Antihypertensive activities of a solid-state culture of Taiwanofungus camphoratus (Chang-Chih) in spontaneously hypertensive rats,” Bioscience, Biotechnology and Biochemistry, vol. 71, no. 1, pp. 23–30, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Abdullah, S. M. Ismail, N. Aminudin, A. S. Shuib, and B. F. Lau, “Evaluation of selected culinary-medicinal mushrooms for antioxidant and ACE inhibitory activities,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 464238, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Sun, H. Xu, and F. Xu, “Astragalus injection for hypertensive renal damage: a systematic review,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 929025, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. K. Verma, V. Jain, and D. P. Singh, “Effect of Pueraria tuberosa DC. (Indian Kudzu) on blood pressure, fibrinolysis and oxidative stress in patients with stage 1 hypertension,” Pakistan Journal of Biological Sciences, vol. 15, no. 15, pp. 742–747, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Xiong, X. Yang, Y. Liu, Y. Zhang, P. Wang, and J. Wang, “Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science,” Hypertension Research, vol. 36, no. 7, pp. 570–579, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Chen, D.-Y. Fu, Y. Chen et al., “Effects of Chinese herbal medicine Yiqi Huaju Formula on hypertensive patients with metabolic syndrome: a randomized, placebo-controlled trial,” Journal of Chinese Integrative Medicine, vol. 11, no. 3, pp. 184–194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Midoh, N. Miyazawa, and F. Eguchi, “Effects of a hot-water extract of porcini (Boletus aestivalis) mushrooms on the blood pressure and heart rate of spontaneously hypertensive rats,” Bioscience, Biotechnology and Biochemistry, vol. 77, no. 8, pp. 1769–1772, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. O. S. M. Bopda, F. Longo, T. N. Bella et al., “Antihypertensive activities of the aqueous extract of Kalanchoe pinnata (Crassulaceae) in high salt-loaded rats,” Journal of Ethnopharmacology, vol. 153, no. 2, pp. 400–407, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. X. J. Xiong, W. Liu, X. C. Yang et al., “Ginkgo biloba extract for essential hypertension: a systemic review,” Phytomedicine, vol. 21, no. 10, pp. 1131–1136, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Ramesar, H. Baijnath, T. Govender, and I. Mackraj, “Angiotensin I-converting enzyme inhibitor activity of nutritive plants in KwaZulu-Natal,” Journal of Medicinal Food, vol. 11, no. 2, pp. 331–336, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. X.-F. Pan, W. Shao, and G.-H. Chen, “Efficacy observation of combination of Lumbrukinase Capsule and Probucol Tablet in treating cerebral infarction patients' unstable atheromatous plaque of the carotid artery,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 31, pp. 1479–1482, 2011. View at Google Scholar · View at Scopus
  25. C.-H. Lai, C.-K. Han, M. A. Shibu et al., “Lumbrokinase from earthworm extract ameliorates second-hand smoke-induced cardiac fibrosis,” Environmental Toxicology, vol. 30, no. 10, pp. 1216–1225, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. C. K. Lee, J. S. Shin, B. S. Kim, I. H. Cho, Y. S. Kim, and E. B. Lee, “Antithrombotic effects by oral administration of novel proteinase fraction from earthworm Eisenia andrei on venous thrombosis model in rats,” Archives of Pharmacal Research, vol. 30, no. 4, pp. 475–480, 2007. View at Publisher · View at Google Scholar
  27. D. W. Cushman and H. S. Cheung, “Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung,” Biochemical Pharmacology, vol. 20, no. 7, pp. 1637–1648, 1971. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Sato, T. Toyoda, A. Shimizu-Ibuka et al., “Novel angiotensin I-converting enzyme inhibitory peptides found in a thermolysin-treated elastin with antihypertensive activity,” Bioscience, Biotechnology and Biochemistry, vol. 76, no. 7, pp. 1329–1333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Khazaei and B. Barmaki, “Role of exogenous nitric oxide donor in treatment of decompensated hemorrhagic shock in normotensive and hypertensive rats,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 365195, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. P. M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P. K. Whelton, and J. He, “Global burden of hypertension: analysis of worldwide data,” The Lancet, vol. 365, no. 9455, pp. 217–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Y. Wang, L. Tull, E. Cooper, N. Wang, and D. Liu, “Recombinant protein production of earthworm lumbrokinase for potential antithrombotic application,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 783971, 8 pages, 2013. View at Publisher · View at Google Scholar
  32. M. Kasim, A. A. Kiat, M. S. Rohman, Y. Hanifah, and H. Kiat, “Improved myocardial perfusion in stable angina pectoris by oral lumbrokinase: a pilot study,” Journal of Alternative and Complementary Medicine, vol. 15, no. 5, pp. 539–544, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C.-H. Liu, Y.-W. Lin, N.-Y. Tang, H.-J. Liu, C.-Y. Huang, and C.-L. Hsieh, “Effect of oral administration of Pheretima aspergillum (earthworm) in rats with cerebral infarction induced by middle-cerebral artery occlusion,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 10, no. 1, pp. 66–82, 2012. View at Google Scholar · View at Scopus
  34. X.-H. Li, D.-X. Zhang, J.-F. Xu et al., “Effect of earthworm decoction on airway inflammation of bronchial asthma in guinea pigs,” Zhongguo Zhong Yao Za Zhi, vol. 32, no. 14, pp. 1445–1448, 2007. View at Google Scholar · View at Scopus
  35. X.-P. Liu, Y.-J. Pang, W.-W. Zhu et al., “Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways,” Clinical and Experimental Pharmacology and Physiology, vol. 36, no. 3, pp. 287–296, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. H. H. Zreikat, S. E. Harpe, P. W. Slattum, D. P. Mays, P. A. Essah, and K. I. Cheang, “Effect of renin-angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndrome,” Metabolism, vol. 63, no. 3, pp. 392–399, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Pruthi, A. Mccurley, M. Aronovitz, C. Galayda, S. A. Karumanchi, and I. Z. Jaffe, “Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 2, pp. 355–364, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Xanthakis and R. S. Vasan, “Aldosterone and the risk of hypertension,” Current Hypertension Reports, vol. 15, no. 2, pp. 102–107, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Fernandes, Z. B. Fortes, D. E. Casarini et al., “Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR,” Regulatory Peptides, vol. 127, no. 1–3, pp. 183–189, 2005. View at Publisher · View at Google Scholar · View at Scopus